Bluejay Diagnostics, Inc. (BJDX)

NASDAQ: BJDX · IEX Real-Time Price · USD

0.551

-0.059 (-9.67%)

At close: Apr 25, 2024, 4:00 PM

0.619

+0.068 (12.38%)

After-hours: Apr 25, 2024, 6:14 PM EDT

Bluejay Diagnostics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	0	0.25	0	0	0
Cost of Revenue	0	0.2	0	0	0
Gross Profit	0	0.05	0	0	0
Selling, General & Admin	4.6	5.21	2.08	0.67	1.18
Research & Development	5.71	4.15	1.15	0.53	0.45
Operating Expenses	10.31	9.37	3.23	1.2	1.63
Operating Income	-10.31	-9.32	-3.23	-1.2	-1.63
Interest Expense / Income	0	0	0.37	0.03	0.05
Other Expense / Income	-0.36	-0.02	-0.11	-0.07	-0.86
Pretax Income	-9.95	-9.3	-3.49	-1.16	-0.82
Net Income	-9.95	-9.3	-3.49	-1.16	-0.82
Shares Outstanding (Basic)	1	1	0	0	0
Shares Outstanding (Diluted)	1	1	0	0	0
Shares Change	8.76%	136.60%	170.79%	-	-
EPS (Basic)	-9.08	-9.22	-8.20	-7.40	-5.20
EPS (Diluted)	-9.08	-9.22	-8.20	-7.40	-5.20
Free Cash Flow	-9.02	-8.94	-4.39	-0.51	-1.7
Free Cash Flow Per Share	-8.22	-8.87	-10.30	-3.23	-10.78
Gross Margin	-	19.64%	-	-	-
Operating Margin	-	-3741.48%	-	-	-
Profit Margin	-	-3733.11%	-	-	-
Free Cash Flow Margin	-	-3590.13%	-	-	-
EBITDA	-9.17	-8.99	-2.98	-0.97	-0.62
EBITDA Margin	-	-3610.09%	-	-	-
Depreciation & Amortization	0.78	0.31	0.15	0.16	0.14
EBIT	-9.95	-9.3	-3.12	-1.13	-0.77
EBIT Margin	-	-3733.11%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).